CY1112900T1 - Φαρμακευτικες συνθεσεις που βασιζονται επι ανταγωνιστων υποδοχεα κινινης β2 και κορτικοστεροειδων και χρηση αυτων - Google Patents

Φαρμακευτικες συνθεσεις που βασιζονται επι ανταγωνιστων υποδοχεα κινινης β2 και κορτικοστεροειδων και χρηση αυτων

Info

Publication number
CY1112900T1
CY1112900T1 CY20121100615T CY121100615T CY1112900T1 CY 1112900 T1 CY1112900 T1 CY 1112900T1 CY 20121100615 T CY20121100615 T CY 20121100615T CY 121100615 T CY121100615 T CY 121100615T CY 1112900 T1 CY1112900 T1 CY 1112900T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
cortico
kinin
competitive
compositions based
Prior art date
Application number
CY20121100615T
Other languages
English (en)
Inventor
Sandro Giuliani
Carlo Alberto Maggi
Original Assignee
Istituto Luso Farmaco D'italia S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Luso Farmaco D'italia S.P.A. filed Critical Istituto Luso Farmaco D'italia S.P.A.
Publication of CY1112900T1 publication Critical patent/CY1112900T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Αποκαλύπτονται φαρμακευτικές συνθέσεις που περιέχουν, ως δραστικά συστατικά, μείγμα ενός κορτικοστεροειδούς και ενός ανταγωνιστή υποδοχέα κινίνης Β2. Οι εν λόγω συνθέσεις έχουν αποδειχθεί ιδιαιτέρως αποτελεσματικές, ειδικά στην θεραπεία φλεγμονωδών διαταραχών, όπως άσθματος, οφθαλμικών ή δερματολογικών διαταραχών και πάνω από όλα, όσον αφορά τους συνδέσμους, αρθρίτιδας.
CY20121100615T 2008-07-11 2012-07-10 Φαρμακευτικες συνθεσεις που βασιζονται επι ανταγωνιστων υποδοχεα κινινης β2 και κορτικοστεροειδων και χρηση αυτων CY1112900T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A001264A IT1391236B1 (it) 2008-07-11 2008-07-11 Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
EP09793880A EP2303268B1 (en) 2008-07-11 2009-07-03 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Publications (1)

Publication Number Publication Date
CY1112900T1 true CY1112900T1 (el) 2016-04-13

Family

ID=40466843

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100615T CY1112900T1 (el) 2008-07-11 2012-07-10 Φαρμακευτικες συνθεσεις που βασιζονται επι ανταγωνιστων υποδοχεα κινινης β2 και κορτικοστεροειδων και χρηση αυτων

Country Status (36)

Country Link
US (1) US8476276B2 (el)
EP (1) EP2303268B1 (el)
JP (1) JP5791501B2 (el)
KR (1) KR101656324B1 (el)
CN (1) CN102088975B (el)
AP (1) AP2803A (el)
AR (1) AR072734A1 (el)
AU (1) AU2009267416B2 (el)
BR (1) BRPI0915866A2 (el)
CA (1) CA2730420A1 (el)
CO (1) CO6341556A2 (el)
CR (1) CR20110021A (el)
CY (1) CY1112900T1 (el)
DK (1) DK2303268T3 (el)
EA (1) EA019903B1 (el)
EC (1) ECSP11010752A (el)
ES (1) ES2389872T3 (el)
GE (1) GEP20135792B (el)
HK (1) HK1158547A1 (el)
HN (1) HN2011000089A (el)
HR (1) HRP20120678T1 (el)
IL (1) IL210554A0 (el)
IT (1) IT1391236B1 (el)
MA (1) MA32542B1 (el)
MX (1) MX2011000350A (el)
MY (1) MY150477A (el)
NI (1) NI201100014A (el)
NZ (1) NZ590427A (el)
PL (1) PL2303268T3 (el)
PT (1) PT2303268E (el)
RS (1) RS52418B (el)
SI (1) SI2303268T1 (el)
TW (1) TWI499419B (el)
UA (1) UA100060C2 (el)
WO (1) WO2010003601A1 (el)
ZA (1) ZA201100287B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
MX2015012650A (es) * 2013-03-14 2016-06-21 Shire Human Genetic Therapies Metodos para el tratamiento de angioedema mediado receptores debradicinina b2.
CN104072585A (zh) * 2014-07-21 2014-10-01 成都圣诺生物科技股份有限公司 一种合成艾替班特的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000696A1 (en) * 2001-06-26 2003-01-03 Metaphore Pharmaceuticals, Inc. COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP1894559A1 (en) * 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation

Also Published As

Publication number Publication date
KR20110044970A (ko) 2011-05-03
EP2303268B1 (en) 2012-06-20
HRP20120678T1 (hr) 2012-09-30
HK1158547A1 (en) 2012-07-20
CR20110021A (es) 2011-07-11
MY150477A (en) 2014-01-30
ECSP11010752A (es) 2011-04-29
EA019903B1 (ru) 2014-07-30
UA100060C2 (uk) 2012-11-12
AR072734A1 (es) 2010-09-15
WO2010003601A1 (en) 2010-01-14
CA2730420A1 (en) 2010-01-14
AP2011005572A0 (en) 2011-02-28
IT1391236B1 (it) 2011-12-01
NZ590427A (en) 2012-09-28
CN102088975B (zh) 2013-08-21
NI201100014A (es) 2011-09-13
AU2009267416B2 (en) 2013-09-12
US20110112011A1 (en) 2011-05-12
RS52418B (en) 2013-02-28
JP5791501B2 (ja) 2015-10-07
EA201100013A1 (ru) 2011-08-30
TW201006471A (en) 2010-02-16
TWI499419B (zh) 2015-09-11
MX2011000350A (es) 2011-02-22
BRPI0915866A2 (pt) 2015-11-03
CO6341556A2 (es) 2011-11-21
ITMI20081264A1 (it) 2010-01-12
IL210554A0 (en) 2011-03-31
PL2303268T3 (pl) 2012-11-30
EP2303268A1 (en) 2011-04-06
KR101656324B1 (ko) 2016-09-09
AU2009267416A1 (en) 2010-01-14
HN2011000089A (es) 2013-01-28
GEP20135792B (en) 2013-03-25
JP2011527296A (ja) 2011-10-27
MA32542B1 (fr) 2011-08-01
AP2803A (en) 2013-11-30
US8476276B2 (en) 2013-07-02
SI2303268T1 (sl) 2012-10-30
ZA201100287B (en) 2012-03-28
PT2303268E (pt) 2012-09-24
ES2389872T3 (es) 2012-11-02
DK2303268T3 (da) 2012-07-23
CN102088975A (zh) 2011-06-08
WO2010003601A8 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
CY1120159T1 (el) Ενωσεις που εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα
CY1116779T1 (el) Αμιδο ενωσεις και η χρηση τους ως φαρμακευτικες ουσιες
CY1116892T1 (el) Ενωσεις οι οποιες εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
CY1113315T1 (el) Ιμιδαζολοκαρβοξαμιδια
CY1110199T1 (el) Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων
BRPI0518281A2 (pt) inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos
DE602007010781D1 (de) N- (phenylmethyl) -2- (1h-pyrazol-4-yl) acetamid-derivate als p2x7-antagonisten zur behandlung von schmerzen, entzündungen und neurodegeneration
EA201071291A3 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
BR112013006395A2 (pt) moduladores do receptor de estrogênio e seus usos.
BR112012020273A2 (pt) Compostos de pirazolopiridina, pirazolopirazina, pirazolopirimidina, pirazolotiofeno e pirazolotiazol como pontencializadores alostéricos de mglur4, composições e métodos de tratamento de disfunção neurológica
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
EA201001253A1 (ru) N,n-дизамещенные аминоалкилбифенилы в качестве антагонистов рецепторов простагландина d
CY1113159T1 (el) Ανταγωνιστες υποδοχεα γλυκαγονης, παρασκευη και θεραπευτικες χρησεις
ATE469658T1 (de) Kombinationstherapien gegen multiple toll-like- rezeptoren und ihre verwendung
EA200700251A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
EA200970302A1 (ru) Тиофенпиразолопиримидиновые соединения
CY1110854T1 (el) Πυραζολοπυριμιδινες θειαζολιου ως ανταγωνιστες υποδοχεων crf1
CY1118044T1 (el) Παρασκευασμα συνδυασμου με ανταγωνιστη και κορτικοστεροειδες
EA200970341A1 (ru) Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов
ATE538100T1 (de) Aminotetrahydroindazoloessigsäuren
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
WO2008150495A3 (en) Vwf aptamer formulations and methods for use